Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...

Discover the top mobile app development tools for 2025, designed to accelerate app creation and improve user experience. From low-code solutions to comprehensive IDEs, find the right tools for your ...

MCP is the Model Context Protocol, introduced by Anthropic last year to act as the “USB-C” interface for connecting AI ...

The modern-day financial markets landscape is powered by speed, automation, and data intelligence. Traders have increasingly ...

Discover how AI, flow chemistry, and NMR come together in the PiPAC project to revolutionize scalable and autonomous API ...

CMS compliance deadlines and heightened cybersecurity expectations are accelerating payer interoperability and utilization management modernization while shifting vendor selection toward platforms ...

One of the great myths of programmatic advertising is the illusion of algorithms replacing humans. In truth, the programmatic industry relies heavily on human relationships and handshake agreements.

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

X has announced a new pay-per-use self-serve API model in hopes of luring developers back to the platform. Credit: Gabby Jones/Bloomberg via Getty Images Good news! Elon Musk's X has heard the cries ...

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will ...

ChatGPT adoption is accelerating at a scale rarely seen in technology. By mid-2025, around 700 million people worldwide were using it every week, sending 18 billion messages, which is roughly 10% of ...

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform. The machine learning platform, called Lilly TuneLab, allows selected ...